Source 1review2026PMC
Toolkit/nanoparticles
nanoparticles
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The supplied web research summary lists nanoparticles as an explicit delivery component supported by therapeutic miRNA and siRNA studies or reviews in TNBC ncRNA therapy.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
payload deliveryTechniques
Structural CharacterizationTarget processes
No target processes tagged yet.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2review2021Cancers
Ranked Claims
Exosomes, nanoparticles, liposomes, aptamer-siRNA conjugates, and antisense oligonucleotides are presented in the supplied summary as recurring or relevant component classes for TNBC ncRNA therapeutics.
The review discusses small molecule inhibitors, nanoparticles, manipulated exosomes, and miRNAs as targeting approaches to inhibit tumor invasion and remodel the tumor microenvironment to enhance treatment efficacy.
Approval Evidence
2 sources2 linked approval claimsfirst-pass slug nanoparticles
The supplied web research summary lists nanoparticles as an explicit delivery component supported by therapeutic miRNA and siRNA studies or reviews in TNBC ncRNA therapy.
Source:
This review discusses the roles of different cellular and structural tumor components in regulating the metastatic process, targeting approaches using small molecule inhibitors, nanoparticles, manipulated exosomes, and miRNAs to inhibit tumor invasion...
Source:
delivery modality recurrencesupports
Exosomes, nanoparticles, liposomes, aptamer-siRNA conjugates, and antisense oligonucleotides are presented in the supplied summary as recurring or relevant component classes for TNBC ncRNA therapeutics.
Source:
therapeutic strategysupports
The review discusses small molecule inhibitors, nanoparticles, manipulated exosomes, and miRNAs as targeting approaches to inhibit tumor invasion and remodel the tumor microenvironment to enhance treatment efficacy.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.
- 2.